Abintus Bio

0 followers


Abintus Bio is leading the field of in vivo immune cell reprogramming. Abintus Bio is pursuing products that modulate immune cells from within their native environment to enhance patient access and patient outcomes.

Industries

Employees

11-50

Links

Org chart

Nicholas A. Boyle
President & CEO

Nicholas A. Boyle

Collapse
Derek Ostertag
Chief Scientific Officer
Douglas J. Jolly
Chief Advisor
David D. Phinney
General Counsel
Jaclyn Miller, MBA
Accounting Consultant